NAGE

NAGE P/E Ratio
P/E Ratio as of Nov 4, 2026: 13.39
Average13.46
Median13.39
Minimum12.38
Maximum14.45
13.39
1.43 (9.65%)past month
The P/E ratio for NAGE is 13.39 as of Nov 4, 2026. This represents a decrease of -33.75% compared to its 12-month average P/E ratio of 20.21. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Niagen Bioscience Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Niagen Bioscience Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Niagen Bioscience Inc to industry peers.
Niagen Bioscience Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Niagen Bioscience Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Niagen Bioscience Inc to industry peers.
NAGE P/E Ratio Insights
See Niagen Bioscience Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in NAGE
Order type
Buy in
Order amount
Est. shares
0 shares
NAGE P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Nov 2, 2026 | $2.40 | 12.75 |
| Oct 1, 2026 | $2.68 | 14.24 |
| Sep 1, 2026 | $3.13 | 16.63 |
| Aug 3, 2026 | $3.53 | 18.76 |
| Jul 1, 2026 | $3.33 | 15.25 |
| Jun 1, 2026 | $3.61 | 16.54 |
| May 1, 2026 | $4.85 | 23.72 |
| Apr 1, 2026 | $4.52 | 22.10 |
| Mar 2, 2026 | $4.99 | 24.40 |
| Feb 2, 2026 | $6.09 | 25.02 |
| Jan 2, 2026 | $6.25 | 25.68 |
NAGE End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 13.39 | -48.76% |
| 2025 | 26.13 | -90.69% |
| 2024 | 280.69 | -1,800.12% |
| 2023 | -16.51 | +194.30% |
| 2022 | -5.61 | -39.29% |
| 2021 | -9.24 | — |
FAQs About Niagen Bioscience Inc (NAGE) P/E ratio
The latest P/E ratio of NAGE is 13.39, as of Nov 4, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Niagen Bioscience Inc’s last 12-month average P/E ratio is 20.21, compared to its current P/E ratio of 13.39. This reflects a decrease of -33.75%.
Niagen Bioscience Inc’s current P/E ratio of 13.39 is lower than its last 12-month average P/E of 20.21. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Niagen Bioscience Inc’s average P/E ratio over the last 3 years is 39.76. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Niagen Bioscience Inc’s average P/E ratio over the last 5 years is 20.28. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
NAGE P/E Ratio Insights
See Niagen Bioscience Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in NAGE
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.